Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Sell
41
ELF Quote, Financials, Valuation and Earnings
Last price:
$131.80
Seasonality move
:
5.91%
Day range:
$127.22 - $131.22
52-week range:
$98.50 - $221.83
Dividend yield:
0%
P/E ratio:
69.70x
P/S ratio:
6.18x
P/B ratio:
9.98x
Volume:
730.3K
Avg. volume:
2.3M
1-year change:
-10.35%
Market cap:
$7.3B
Revenue:
$1B
EPS (TTM):
$1.85
Analysts' Opinion
-
Consensus Ratinge.l.f. Beauty has received a consensus rating of Buy. The company's average rating is a Buy based on 11 Buy ratings, 5 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $158.36, e.l.f. Beauty has an estimated upside of 22.81% from its current price of $128.95.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $115.00 representing 10.82% downside risk from its current price of $128.95.
Fair Value
-
According to the consensus of 16 analysts, e.l.f. Beauty has 22.81% upside to fair value with a price target of $158.36 per share.
ELF vs. S&P 500
-
Over the past 5 trading days, e.l.f. Beauty has underperformed the S&P 500 by -9.64% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
e.l.f. Beauty does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
e.l.f. Beauty has grown year-over-year revenues for 23 quarters straight. In the most recent quarter e.l.f. Beauty reported revenues of $301.1M.
Earnings Growth
-
e.l.f. Beauty earnings have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter e.l.f. Beauty reported earnings per share of $0.33.
Enterprise value:
7.4B
EV / Invested capital:
7.54x
Price / LTM sales:
6.18x
EV / EBIT:
55.99x
EV / Revenue:
6.10x
PEG ratio (5yr expected):
4.12x
EV / Free cash flow:
326.62x
Price / Operating cash flow:
331.26x
Enterprise value / EBITDA:
41.24x
Gross Profit (TTM):
$864.5M
Return On Assets:
9.95%
Net Income Margin (TTM):
8.87%
Return On Equity:
16.85%
Return On Invested Capital:
12.52%
Operating Margin:
9.27%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $448.2M | $765.7M | $1.2B | $215.5M | $301.1M | |
| Gross Profit | $294.4M | $532.8M | $864.5M | $152.4M | $214.1M | |
| Operating Income | $47.9M | $132.1M | $127.5M | $40.2M | $27.9M | |
| EBITDA | $71.8M | $158M | $180M | $46.9M | $40.6M | |
| Diluted EPS | $0.63 | $2.14 | $1.85 | $0.58 | $0.33 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $151.8M | $181.3M | $247.4M | $435.4M | $554M | |
| Total Assets | $473.4M | $493M | $542.1M | $746.9M | $1.2B | |
| Current Liabilities | $61M | $71.2M | $71.9M | $152.4M | $310.9M | |
| Total Liabilities | $218.8M | $198.9M | $185.2M | $230.5M | $509.3M | |
| Total Equity | $254.7M | $294.1M | $357M | $516.4M | $727.7M | |
| Total Debt | $132.8M | $113.1M | $94.1M | $63M | $256.9M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $61.8M | $110.1M | $32.3M | $27.9M | $11.2M | |
| Cash From Investing | -$1.9M | -$2.5M | -$285.7M | -$849K | -$1.6M | |
| Cash From Financing | -$16.3M | -$25.2M | $181.8M | -$1.9M | -$22.4M | |
| Free Cash Flow | $59.9M | $107.6M | $22.7M | $27.1M | $9.5M | |
ELF
Sector
Market Cap
$7.3B
$347.3M
Price % of 52-Week High
58.13%
73.63%
Dividend Yield
0%
0%
Shareholder Yield
-0.44%
2.64%
1-Year Price Total Return
-10.35%
-13.33%
Beta (5-Year)
1.487
0.504
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$132.65
200-day SMA
Sell
Level
$155.79
Bollinger Bands (100)
Buy
Level
106.85 - 149.83
Chaikin Money Flow
Buy
Level
31.2M
20-day SMA
Sell
Level
$132.70
Relative Strength Index (RSI14)
Sell
Level
49.51
ADX Line
Buy
Level
7.09
Williams %R
Neutral
Level
-77.1002
50-day SMA
Buy
Level
$121.68
MACD (12, 26)
Buy
Level
2.27
25-day Aroon Oscillator
Buy
Level
48
On Balance Volume
Neutral
Level
16.9M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (14.6096)
Buy
CA Score
(Annual)
Level (1.3068)
Sell
Beneish M-Score
(Annual)
Level (-1.6247)
Buy
Momentum Score
Level (5)
Buy
Ohlson Score
Level (-1.2595)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
e.l.f. Beauty Inc is a multi-brand beauty company that offers inclusive, accessible, clean, vegan and cruelty-free cosmetics and skin care products. The Company's mission is to make the best of beauty accessible to every eye, lip, face, and skin concern. The company offers cosmetic accessories for women which include eyeliner, mascara, false eyelashes, lipstick, the foundation for the face, moisturizer, cleanser, and other tools through its stores and e-commerce channels. The products that the company sells are marketed under the e.l.f. Cosmetics, W3LL PEOPLE and Keys Soulcare brands. It carries out sales within the US and internationally, out of which maximum revenue is generated from the US.
Stock Forecast FAQ
In the current month, ELF has received 11 Buy ratings 5 Hold ratings, and 0 Sell ratings. The ELF average analyst price target in the past 3 months is $158.36.
-
Where Will e.l.f. Beauty Stock Be In 1 Year?
According to analysts, the consensus estimate is that e.l.f. Beauty share price will rise to $158.36 per share over the next 12 months.
-
What Do Analysts Say About e.l.f. Beauty?
Analysts are divided on their view about e.l.f. Beauty share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that e.l.f. Beauty is a Sell and believe this share price will drop from its current level to $115.00.
-
What Is e.l.f. Beauty's Price Target?
The price target for e.l.f. Beauty over the next 1-year time period is forecast to be $158.36 according to 16 Wall Street analysts, 11 of them rate the stock a Buy, 0 rate the stock a Sell, and 5 analysts rate the stock a Hold.
-
Is ELF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for e.l.f. Beauty is a Buy. 11 of 16 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of ELF?
You can purchase shares of e.l.f. Beauty via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase e.l.f. Beauty shares.
-
What Is The e.l.f. Beauty Share Price Today?
e.l.f. Beauty was last trading at $131.80 per share. This represents the most recent stock quote for e.l.f. Beauty. Yesterday, e.l.f. Beauty closed at $128.95 per share.
-
How To Buy e.l.f. Beauty Stock Online?
In order to purchase e.l.f. Beauty stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Sell
40
MSTR alert for Dec 24
MicroStrategy [MSTR] is up 8.05% over the past day.
Sell
26
NUTX alert for Dec 24
Nutex Health [NUTX] is down 0.76% over the past day.
Sell
48
VRNA alert for Dec 24
Verona Pharma PLC [VRNA] is down 0.62% over the past day.
